ACT Wealth Management LLC decreased its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 19.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,329 shares of the company’s stock after selling 325 shares during the quarter. ACT Wealth Management LLC’s holdings in Procter & Gamble were worth $223,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in the business. Atomi Financial Group Inc. lifted its position in shares of Procter & Gamble by 13.0% in the 4th quarter. Atomi Financial Group Inc. now owns 33,849 shares of the company’s stock worth $5,675,000 after purchasing an additional 3,895 shares during the period. Transform Wealth LLC boosted its position in Procter & Gamble by 91.5% during the 4th quarter. Transform Wealth LLC now owns 4,236 shares of the company’s stock valued at $710,000 after acquiring an additional 2,024 shares in the last quarter. Clear Harbor Asset Management LLC grew its holdings in shares of Procter & Gamble by 9.4% during the 4th quarter. Clear Harbor Asset Management LLC now owns 38,978 shares of the company’s stock worth $6,535,000 after acquiring an additional 3,365 shares during the period. ADE LLC raised its position in shares of Procter & Gamble by 2.6% in the 4th quarter. ADE LLC now owns 4,694 shares of the company’s stock worth $787,000 after acquiring an additional 117 shares in the last quarter. Finally, Aspiriant LLC lifted its stake in shares of Procter & Gamble by 8.2% in the 4th quarter. Aspiriant LLC now owns 33,076 shares of the company’s stock valued at $5,545,000 after purchasing an additional 2,510 shares during the period. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Trading Up 1.8 %
NYSE:PG opened at $164.57 on Thursday. The firm has a market capitalization of $387.56 billion, a price-to-earnings ratio of 28.37, a price-to-earnings-growth ratio of 3.63 and a beta of 0.45. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The business has a fifty day moving average price of $169.01 and a 200-day moving average price of $169.41. The Procter & Gamble Company has a one year low of $152.06 and a one year high of $180.43.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.45%. The ex-dividend date of this dividend is Friday, January 24th. Procter & Gamble’s payout ratio is currently 69.48%.
Insider Activity
In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at $7,189,463.68. The trade was a 54.48 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the transaction, the insider now owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This represents a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.18% of the company’s stock.
Analyst Ratings Changes
PG has been the subject of a number of research reports. Stifel Nicolaus decreased their price objective on Procter & Gamble from $167.00 to $161.00 and set a “hold” rating for the company in a report on Friday, January 17th. UBS Group lowered their price target on shares of Procter & Gamble from $196.00 to $189.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. DA Davidson restated a “buy” rating and issued a $209.00 price objective on shares of Procter & Gamble in a report on Friday, December 27th. Barclays lowered their target price on shares of Procter & Gamble from $163.00 to $155.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Finally, Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $179.65.
View Our Latest Research Report on PG
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Why Are These Companies Considered Blue Chips?
- Oracle Announces Game-Changing News for the AI Industry
- What is a Dividend King?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- How to Use the MarketBeat Excel Dividend Calculator
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.